cardamyst 35 MG/ACTUAT Nasal Spray
- RxCUI
- 2730313
- RxNorm name
- cardamyst 35 MG/ACTUAT Nasal Spray
- Display name
- cardamyst 35 MG/ACTUAT Nasal Spray
- Full name
- cardamyst 35 MG/ACTUAT Nasal Spray
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cardamyst | ETRIPAMIL | Milestone Pharmaceuticals USA, Inc. | a92170b9-4f93-4b83-b2cd-cb85c52821cd | 2025-12-08 | Warnings, Adverse reactions | 2730313 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a92170b9-4f93-4b83-b2cd-cb85c52821cd | cardamyst 35 MG/ACTUAT Nasal Spray | PSN | 1 | These highlights do not include all the information needed to use CARDAMYST TM safely and effectively. See full prescribing information for CARDAMYST TM . CARDAMYST TM (etripamil) nasal spray Initial U.S. Approval: 2025 | 20251208 |
| a92170b9-4f93-4b83-b2cd-cb85c52821cd | Cardamyst 35 MG/ACTUAT Nasal Spray | SY | 1 | These highlights do not include all the information needed to use CARDAMYST TM safely and effectively. See full prescribing information for CARDAMYST TM . CARDAMYST TM (etripamil) nasal spray Initial U.S. Approval: 2025 | 20251208 |
| a92170b9-4f93-4b83-b2cd-cb85c52821cd | etripamil 35 MG/ACTUAT Nasal Spray [Cardamyst] | SBD | 1 | These highlights do not include all the information needed to use CARDAMYST TM safely and effectively. See full prescribing information for CARDAMYST TM . CARDAMYST TM (etripamil) nasal spray Initial U.S. Approval: 2025 | 20251208 |